Ron Waksman

Ron Waksman

Interventional cardiologist / Cardiologist
MedStar Heart and Vascular Institute - Washington DC, United States

Latest contributions

Magmaris Magnesium BRS: safety and performance of an advanced and innovative technology

16 May 2017 – From EuroPCR 2017

Consult this session presented by M. Joner, W. Wijns and M.K.Y. Lee if you want to find out more about the best indication for patient selection in 2017, ultrathin, bioresorbable polymer sirolimus-eluting stents vs thin, durable polymer everolimus-eluting stents in patients undergoing coronary revascularisatio; the new update on Dual Antiplatelet Therapy (DAPT) VALIDATE-SWEDEHEART, TROPICAL-ACS and RE-DUAL PCI from the ESC 2017 and more...

Effectiveness of Excimer laser for heavily calcified lesions

17 May 2017 – From EuroPCR 2017

Vulnerable plaque - Advances in diagnosis and treatment

17 May 2017 – From EuroPCR 2017

Consult this session to understand the pathology of the vulnerable plaque, gain experience with the role of intra-coronary imaging to detect it, be updated on the latest treatment strategies.

BVS / BRS trial updates and registries

16 May 2017 – From EuroPCR 2017

Device-based management in advanced chronic heart failure: are we there yet?

16 May 2017 – From EuroPCR 2017

Innovations at the crossroad: bioresorbable scaffolds

15 May 2017 – From PCR Innovators Day Paris 2017

Consult this innovation session on bioresorbable scaffolds presented by Speaker: P.W. Serruys during PCR Innovators Day Paris 2017.

Vulnerable plaque: future directions

19 May 2016 – From EuroPCR 2016

Panellists: T. Akasaka, K. Al-Shaibi, V. Farooq, D. Holmes, P.G. Steg and R. Virmani

Consult the session video on vulnerable plaque: future directions from EuroPCR 2016.

Resorbable magnesium scaffold Magmaris: opening a new era

18 May 2016 – From EuroPCR 2016

Does the drug-eluting platform matter?

20 May 2015 – From EuroPCR 2015

Clinical value of IVUS during ACS: when you lose your way

23 May 2013 – From EuroPCR 2013